HBS Kraft Precision Medicine Accelerator Workshop: Making Non-Profit and Pharma Master Protocol Collaborations Work

On Thursday, April 11, 2019, Harvard Business School's Kraft Precision Medicine Accelerator convenes a workshop entitled "Making Non-Profit and Pharma Master Protocol Collaborations Work." 

Laura Peace, CRI Consultant, Head of Clinical Alliances, Clinical Accelerator, participates in a panel discussion, "How to Optimize Execution of a Master Protocol," at 10:30 a.m.-11:15 a.m.

Fellow panellists include Brian Alexander, MD, MPH, Senior Vice President, Clinical Development, Foundation Medicine Institute; Amy Burd, PhD, Vice President, Research Strategy, Leukemia & Lymphoma Society; and Karen Dietz, JD, MBA, In-House Legal Counsel, Multiple Myeloma Research Foundation. Richard Hamermesh, Faculty Co-Chair, HBS Kraft Precision Medicine Accelerator, Harvard Business School, moderates. 

The event will take place at Harvard Business School, Tata Hall – Room 120, 125 Western Ave, Allston, MA 02163. 

Join our email list for updates on cancer immunotherapy research, events, and opportunities to get involved with the Cancer Research Institute. Sign up below and be a force for change in the fight against cancer.

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

Father and son